title: Immune checkpoint inhibitors in malignant pleural mesothelioma: promises and challenges.
authors.affiliation: a Thoracic and GU Oncology Unit, Department of Medical Oncology , Cliniche Humanitas Gavazzeni , Bergamo , Italy.
authors.forename: Giovanni Luca
authors.initials: GL
authors.lastname: Ceresoli
authors.affiliation: a Thoracic and GU Oncology Unit, Department of Medical Oncology , Cliniche Humanitas Gavazzeni , Bergamo , Italy.
authors.forename: Maria
authors.initials: M
authors.lastname: Bonomi
authors.affiliation: a Thoracic and GU Oncology Unit, Department of Medical Oncology , Cliniche Humanitas Gavazzeni , Bergamo , Italy.
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Sauta
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008175:Lung Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D008654:Mesothelioma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D000086002:Mesothelioma, Malignant; D010997:Pleural Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D011379:Prognosis
keywords: Malignant pleural mesothelioma; immune-checkpoint inhibitors; immunotherapy